Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 651 to 700 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 651\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ebp50-pdz interactor of 64 kda (epi64 protein). [source:swissprot;acc:q9bxi6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5168.43\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 4597.44\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.1242\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 652\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent short transient receptor potential channel 5 (trpc5) (htrp-5) (htrp5). [source:swissprot;acc:q9ul62]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 653\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent methionyl-trna synthetase (ec 6.1.1.10) (methionine--trna ligase) (metrs). [source:swissprot;acc:p56192]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5560.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6248.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12378\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 654\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h3.3 (h3.a) (h3.b) (h3.3q). [source:swissprot;acc:p06351]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4088.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 4593.43\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.12346\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 655\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj1099d15.1 (putative dnaj protein). [source:sptrembl;acc:q9h4j9]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 656\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent apolipoprotein a-i binding protein; apoa-i binding protein. [source:refseq;acc:nm\_144772]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6139.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6893.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12293\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 657\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rgs19-interacting protein 1 (gaip c-terminus interacting protein gipc) (rgs-gaip interacting protein) (tax interaction protein 2) (tip-2). [source:swissprot;acc:o14908]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6079.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6824.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12258\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 658\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent apical-like protein (apxl protein). [source:swissprot;acc:q13796]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6088.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6834.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12254\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 659\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent shroom-related protein; f-actin-binding protein; likely ortholog of mouse shroom. [source:refseq;acc:nm\_020859]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6089.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6835.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12253\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 660\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent u2 small nuclear ribonucleoprotein auxiliary factor 35 kda subunit related-protein 1. [source:swissprot;acc:q15695]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5575.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6254.85\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.12191\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 661\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent step ii splicing factor slu7. [source:refseq;acc:nm\_006425]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 662\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent partitioning defective-6 homolog gamma (par-6 gamma) (par6d). [source:swissprot;acc:q9byg4]\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6374.65\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7145.59\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.12094\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 663\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tubby protein homolog. [source:swissprot;acc:p50607]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 664\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein kinase c, iota type (ec 2.7.1.37) (npkc-iota) (atypical protein kinase c-lamda/iota) (apkc-lambda/iota). [source:swissprot;acc:p41743]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 665\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent numb protein homolog (h-numb) (protein s171). [source:swissprot;acc:p49757]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 666\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tbc1 domain family member 5. [source:swissprot;acc:q92609]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 667\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tubby related protein 1 (tubby-like protein 1). [source:swissprot;acc:o00294]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 668\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar protein sorting 29 (vesicle protein sorting 29) (hvps29) (mds007) (pep11) (dc7/dc15). [source:swissprot;acc:q9ubq0]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 669\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent numb-like protein (numb-r). [source:swissprot;acc:q9y6r0]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 670\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tubby related protein 3 (tubby-like protein 3). [source:swissprot;acc:o75386]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 671\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar protein sorting 35 (vesicle protein sorting 35) (hvps35) (maternal-embryonic 3). [source:swissprot;acc:q96qk1]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 672\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein kinase c, zeta type (ec 2.7.1.37) (npkc-zeta). [source:swissprot;acc:q05513]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 673\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor btf3 (rna polymerase b transcription factor 3). [source:swissprot;acc:p20290]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6933.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7766.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1202\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 674\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sprouty homolog 4 (spry-4). [source:swissprot;acc:q9c004]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5549.2\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6215.42\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.12006\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 675\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sprouty homolog 3 (spry-3). [source:swissprot;acc:o43610]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 676\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sprouty homolog 1 (spry-1) (fragment). [source:swissprot;acc:o43609]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 677\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sprouty homolog 2 (spry-2). [source:swissprot;acc:o43597]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 678\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor btf3 homolog 3. [source:swissprot;acc:q13892]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6938.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7770.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11998\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 679\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adenylosuccinate synthase-like 1. [source:refseq;acc:nm\_152328]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6503.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7282.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11992\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 680\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adenylosuccinate synthetase (ec 6.3.4.4) (imp--aspartate ligase) (adss) (ampsase). [source:swissprot;acc:p30520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6503.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7282.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11986\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 681\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein l24-like; 60s ribosomal protein l30 isolog; my024 protein; homolog of yeast ribosomal like protein 24. [source:refseq;acc:nm\_016304]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7170.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8029.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11976\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 682\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent syntaxin 12. [source:refseq;acc:nm\_177424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5552.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6217.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1197\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 683\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sh3-containing grb2-like protein 1 (sh3 domain protein 2b) (extra eleven-nineteen leukemia fusion gene) (een) (een fusion partner of mll). [source:swissprot;acc:q99961]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7139.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7994.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11969\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 684\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 9 (eif-3 eta) (eif3 p116) (eif3 p110) (eif3b). [source:swissprot;acc:p55884]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4359.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4880.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11954\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 685\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent metaxin 1. [source:swissprot;acc:q13505]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 9327.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10442.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1195\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 686\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, gamma-1 subunit (ampk gamma-1 chain) (ampkg). [source:swissprot;acc:p54619]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6920.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7747.63\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11949\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 687\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, catalytic alpha-2 chain (ec 2.7.1.-) (ampk alpha-2 chain). [source:swissprot;acc:p54646]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6920.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7747.65\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 688\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, catalytic alpha-1 chain (ec 2.7.1.-) (ampk alpha-1 chain). [source:swissprot;acc:q13131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6920.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7747.6\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 689\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, beta-2 subunit (ampk beta-2 chain). [source:swissprot;acc:o43741]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6920.69\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7747.63\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 690\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, gamma-3 subunit (ampk gamma-3 chain) (ampk gamma3). [source:swissprot;acc:q9ugi9]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 691\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, beta-1 subunit (ampk beta-1 chain) (ampkb). [source:swissprot;acc:q9y478]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 692\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, gamma-2 subunit (ampk gamma-2 chain) (ampk gamma2) (h91620p). [source:swissprot;acc:q9ugj0]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 693\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent j kappa-recombination signal binding protein (rbp-j kappa). [source:swissprot;acc:q06330]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 7725.1\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 8647.74\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11943\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 694\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent human immunodeficiency virus type i enhancer binding protein 3. [source:refseq;acc:nm\_024503]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 695\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 40 (human immunodeficiency virus type i enhancer- binding protein 1) (hiv-ep1) (major histocompatibility complex binding protein 1) (mbp-1) (positive regulatory domain ii binding factor 1) (prdii-bf1). [source:swissprot;acc:p15822]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 696\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent human immunodeficiency virus type i enhancer-binding protein 2 (hiv-ep2). [source:swissprot;acc:p31629]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 697\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sh3-containing grb2-like protein 2 (sh3 domain protein 2a) (endophilin 1) (een-b1). [source:swissprot;acc:q99962]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7105.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7953.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11941\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 698\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent armet protein precursor (arginine-rich protein). [source:swissprot;acc:p55145]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7101.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7949.85\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11939\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 699\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histidine decarboxylase (ec 4.1.1.22) (hdc). [source:swissprot;acc:p19113]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7101.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7949.84\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 700\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein s28. [source:swissprot;acc:p25112]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7161.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8015.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11936\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/